Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daiichi Sankyo, Lilly Explore Pharmacogenomic Marker For Prasugrel

This article was originally published in PharmAsia News

Executive Summary

A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era

You may also be interested in...



Last Gasp Or New Life? 2009’s Novel Products Have Blockbuster Potential

After a 2008 NME approval slate that was heavy on modest specialty products, the 2009 user fee calendar offers the potential for a return of the blockbuster

BMS/Sanofi-Aventis To Study Plavix Efficacy Concerns

Genetics and concomitant PPI use are possible reasons for the anti-platelet drug’s reduced effectiveness in some patients, according to an FDA “Early Communication.”

Thrombosis Events Tied To Gene Mutation In Stent Patients On Clopidogrel

Three independent research teams say they have document a strong link between a metabolizing gene and the prognosis for stented heart disease patients taking the standard anti-platelet medicine Plavix.

Related Content

UsernamePublicRestriction

Register

SC071828

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel